TOBRADEX ST is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Tobramycin; Dexamethasone.
Product ID | 0065-0652_83c0535a-a158-4cbf-b3f8-d1bd6658015b |
NDC | 0065-0652 |
Product Type | Human Prescription Drug |
Proprietary Name | TOBRADEX ST |
Generic Name | Tobramycin / Dexamethasone |
Dosage Form | Suspension/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2010-09-07 |
Marketing Category | NDA / NDA |
Application Number | NDA050818 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | TOBRAMYCIN; DEXAMETHASONE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2010-09-07 |
Marketing End Date | 2021-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-09-09 |
Marketing Category | NDA |
Application Number | NDA050818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-09-07 |
Marketing End Date | 2010-09-07 |
Marketing Category | NDA |
Application Number | NDA050818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-09-07 |
Marketing End Date | 2010-09-07 |
Marketing Category | NDA |
Application Number | NDA050818 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-09-07 |
Ingredient | Strength |
---|---|
TOBRAMYCIN | 3 mg/mL |
SPL SET ID: | d1d48422-8cfc-4e9e-a7f8-56c274d8eb83 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0065-0652 | TOBRADEX ST | tobramycin / dexamethasone |
71776-035 | TobraDex ST | tobramycin / dexamethasone |